Annual Drug Patent Expirations for AUVELITY
Auvelity is a drug marketed by Axsome and is included in one NDA. It is available from one supplier. There are ninety-six patents protecting this drug.
This drug has one hundred and thirty-three patent family members in thirty countries.
The generic ingredient in AUVELITY is bupropion hydrochloride; dextromethorphan hydrobromide. One supplier is listed for this compound. Additional details are available on the bupropion hydrochloride; dextromethorphan hydrobromide profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
